Bioventus divests Advanced Rehabilitation business to Accelmed Partners for $45M

Bioventus has signed a definitive agreement to sell its Advanced Rehabilitation business (Bioness) to Accelmed Partners for total cash consideration of $45 million, including $25 million at close and up to $20 million in earn-outs.

“This agreement reflects our deep respect for the Advanced Rehabilitation business and the many patients who benefit from its life-changing technology.”business.woonsocketcall.com

• 1 source
• business.woonsocketcall.comBioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed PartnersBioventus, Inc.Oct 1, 2024

Summarized from public sources; check the original articles before acting on it.